Mangalam Drugs & Organics Limited (NSE:MANGALAM)
30.56
+0.32 (1.06%)
Apr 7, 2026, 10:29 AM IST
Revenue by Segment
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Source: S&P Global Market Intelligence.